Studies of protracted shock in guinea pigs.
D006631:Amine Oxidase (Copper-Containing) / Q000378:metabolism; D000707:Anaphylaxis / Q000188:drug therapy*; D000818:Animals; D001986:Bronchial Spasm / Q000188:drug therapy / Q000276:immunology; D004357:Drug Synergism; D004837:Epinephrine / Q000378:metabolism / Q000627:therapeutic use; D005029:Ethylenediamines / Q000627:therapeutic use; D006168:Guinea Pigs; D006632:Histamine / Q000009:adverse effects; D006634:Histamine H1 Antagonists / Q000627:therapeutic use*; D010276:Parasympatholytics / Q000627:therapeutic use; D012770:Shock, Cardiogenic / Q000188:drug therapy
D005029:Ethylenediamines; D006634:Histamine H1 Antagonists; D010276:Parasympatholytics; D006632:Histamine; D006631:Amine Oxidase (Copper-Containing); D004837:Epinephrine